Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19461 | 504 | 31.9 | 57% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
494 | 3 | AVIAN DISEASES//AVIAN PATHOLOGY//NEWCASTLE DISEASE VIRUS | 22905 |
1525 | 2 | ADJUVANT//ISCOM//VACCINE | 7477 |
19461 | 1 | LIPOSOMAL ANTIGENS//DRUG DELIVERY SYST DEV//FUSOGENIC LIPIDS | 504 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LIPOSOMAL ANTIGENS | authKW | 363510 | 1% | 100% | 6 |
2 | DRUG DELIVERY SYST DEV | address | 218101 | 1% | 60% | 6 |
3 | FUSOGENIC LIPIDS | authKW | 193870 | 1% | 80% | 4 |
4 | B30 MDP | authKW | 136315 | 1% | 75% | 3 |
5 | IGE UNRESPONSIVENESS | authKW | 121170 | 0% | 100% | 2 |
6 | LIPOSOMAL LIPID A | authKW | 121170 | 0% | 100% | 2 |
7 | MICROENCAPSULATED LIPOSOME SYSTEMS | authKW | 121170 | 0% | 100% | 2 |
8 | SAFETY BLOOD BIOL PROD | address | 100358 | 3% | 13% | 13 |
9 | ADJUVANT ANTIGEN | address | 87233 | 1% | 24% | 6 |
10 | HER2 NEU PEPTIDE | authKW | 80779 | 0% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 6726 | 55% | 0% | 277 |
2 | Allergy | 527 | 5% | 0% | 25 |
3 | Medicine, Research & Experimental | 519 | 13% | 0% | 65 |
4 | Pharmacology & Pharmacy | 164 | 13% | 0% | 65 |
5 | Biochemical Research Methods | 135 | 6% | 0% | 32 |
6 | Biophysics | 108 | 6% | 0% | 32 |
7 | Biochemistry & Molecular Biology | 102 | 16% | 0% | 81 |
8 | Infectious Diseases | 73 | 4% | 0% | 22 |
9 | Cell Biology | 38 | 7% | 0% | 33 |
10 | Biology | 17 | 2% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG DELIVERY SYST DEV | 218101 | 1% | 60% | 6 |
2 | SAFETY BLOOD BIOL PROD | 100358 | 3% | 13% | 13 |
3 | ADJUVANT ANTIGEN | 87233 | 1% | 24% | 6 |
4 | AIDSVACCINE DEV BRANCHSOLAR BLDG | 60585 | 0% | 100% | 1 |
5 | C HABANA | 60585 | 0% | 100% | 1 |
6 | GRP RECH BIOL MED | 60585 | 0% | 100% | 1 |
7 | IMMUNOLOGY GENET | 60585 | 0% | 100% | 1 |
8 | INTERDISCIPLINAR BIOTECHNOL UNIT | 60585 | 0% | 100% | 1 |
9 | LIPID MEMBRANE PHYS CHEM | 60585 | 0% | 100% | 1 |
10 | NEW YORK STATE VET MED VET MICROBIOL | 60585 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IMMUNOLOGICAL COMMUNICATIONS | 17853 | 2% | 4% | 8 |
2 | VACCINE | 6173 | 9% | 0% | 43 |
3 | IMMUNOLOGY | 5399 | 6% | 0% | 28 |
4 | IMMUNOLOGY LETTERS | 4818 | 4% | 0% | 21 |
5 | JOURNAL OF LIPOSOME RESEARCH | 2570 | 1% | 1% | 5 |
6 | JOURNAL OF DRUG TARGETING | 1898 | 1% | 0% | 7 |
7 | INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY | 1718 | 2% | 0% | 11 |
8 | DELAWARE MEDICAL JOURNAL | 1407 | 0% | 2% | 1 |
9 | CANADIAN JOURNAL OF BIOCHEMISTRY | 1182 | 1% | 1% | 3 |
10 | CYTOKINES AND MOLECULAR THERAPY | 1120 | 0% | 2% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LIPOSOMAL ANTIGENS | 363510 | 1% | 100% | 6 | Search LIPOSOMAL+ANTIGENS | Search LIPOSOMAL+ANTIGENS |
2 | FUSOGENIC LIPIDS | 193870 | 1% | 80% | 4 | Search FUSOGENIC+LIPIDS | Search FUSOGENIC+LIPIDS |
3 | B30 MDP | 136315 | 1% | 75% | 3 | Search B30+MDP | Search B30+MDP |
4 | IGE UNRESPONSIVENESS | 121170 | 0% | 100% | 2 | Search IGE+UNRESPONSIVENESS | Search IGE+UNRESPONSIVENESS |
5 | LIPOSOMAL LIPID A | 121170 | 0% | 100% | 2 | Search LIPOSOMAL+LIPID+A | Search LIPOSOMAL+LIPID+A |
6 | MICROENCAPSULATED LIPOSOME SYSTEMS | 121170 | 0% | 100% | 2 | Search MICROENCAPSULATED+LIPOSOME+SYSTEMS | Search MICROENCAPSULATED+LIPOSOME+SYSTEMS |
7 | HER2 NEU PEPTIDE | 80779 | 0% | 67% | 2 | Search HER2+NEU+PEPTIDE | Search HER2+NEU+PEPTIDE |
8 | REVERSE TARGETING | 80779 | 0% | 67% | 2 | Search REVERSE+TARGETING | Search REVERSE+TARGETING |
9 | LIPOSOMES | 68508 | 22% | 1% | 109 | Search LIPOSOMES | Search LIPOSOMES |
10 | ADJUVANT CARRIER ACTIVITY | 60585 | 0% | 100% | 1 | Search ADJUVANT+CARRIER+ACTIVITY | Search ADJUVANT+CARRIER+ACTIVITY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | UCHIDA, T , TANEICHI, M , (2014) APPLICATION OF SURFACE-LINKED LIPOSOMAL ANTIGENS TO THE DEVELOPMENT OF VACCINES THAT INDUCE BOTH HUMORAL AND CELLULAR IMMUNITY.JAPANESE JOURNAL OF INFECTIOUS DISEASES. VOL. 67. ISSUE 4. P. 235 -244 | 20 | 74% | 0 |
2 | ALVING, CR , (1991) LIPOSOMES AS CARRIERS OF ANTIGENS AND ADJUVANTS.JOURNAL OF IMMUNOLOGICAL METHODS. VOL. 140. ISSUE 1. P. 1 -13 | 36 | 51% | 246 |
3 | GREGORIADIS, G , (1990) IMMUNOLOGICAL ADJUVANTS - A ROLE FOR LIPOSOMES.IMMUNOLOGY TODAY. VOL. 11. ISSUE 3. P. 89-97 | 30 | 54% | 338 |
4 | RAO, M , ALVING, CR , (2000) DELIVERY OF LIPIDS AND LIPOSOMAL PROTEINS TO THE CYTOPLASM AND GOLGI OF ANTIGEN-PRESENTING CELLS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 41. ISSUE 2. P. 171-188 | 30 | 38% | 57 |
5 | UCHIDA, T , TANEICHI, M , (2008) CLINICAL APPLICATION OF SURFACE-LINKED LIPOSOMAL ANTIGENS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 8. ISSUE 2. P. 184-192 | 18 | 51% | 4 |
6 | THERIEN, HM , SHAHUM, E , (1996) DIFFERENTIAL BIODISTRIBUTION OF ENCAPSULATED AND SURFACE-LINKED LIPOSOMAL ANTIGENS.BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES. VOL. 1280. ISSUE 1. P. 91 -97 | 19 | 68% | 4 |
7 | GREGORIADIS, G , GURSEL, I , GURSEL, M , MCCORMACK, B , (1996) LIPOSOMES AS IMMUNOLOGICAL ADJUVANTS AND VACCINE CARRIERS.JOURNAL OF CONTROLLED RELEASE. VOL. 41. ISSUE 1-2. P. 49 -56 | 21 | 54% | 53 |
8 | UCHIDA, T , (2011) DEVELOPMENT OF A CYTOTOXIC T-LYMPHOCYTE-BASED, BROADLY PROTECTIVE INFLUENZA VACCINE.MICROBIOLOGY AND IMMUNOLOGY. VOL. 55. ISSUE 1. P. 19 -27 | 16 | 46% | 6 |
9 | ALVING, CR , WASSEF, NM , (1994) CYTOTOXIC T-LYMPHOCYTES INDUCED BY LIPOSOMAL ANTIGENS - MECHANISMS OF IMMUNOLOGICAL PRESENTATION.AIDS RESEARCH AND HUMAN RETROVIRUSES. VOL. 10. ISSUE . P. S91-S94 | 22 | 55% | 22 |
10 | GREGORIADIS, G , (1994) THE IMMUNOLOGICAL ADJUVANT AND VACCINE CARRIER PROPERTIES OF LIPOSOMES.JOURNAL OF DRUG TARGETING. VOL. 2. ISSUE 5. P. 351-356 | 19 | 61% | 40 |
Classes with closest relation at Level 1 |